Literature DB >> 25301871

Elevated RANTES level is associated with metabolic syndrome and correlated with activated platelets associated markers in healthy younger men.

Tetsuya Ueba1, Shosaku Nomura2, Norihito Inami2, Takashi Yokoi2, Tooru Inoue3.   

Abstract

The objective of this study was to clarify the relationship of regulated on activation normal T cell expressed and secreted (RANTES) levels with metabolic syndrome (MS) and activated platelets-associated markers. We conducted a cross-sectional study of 210 healthy Japanese male volunteers (mean age 41 years old) who did not take any medications and were free of cardiovascular or cerebrovascular disease. The RANTES is correlated with age, diastolic blood pressure, and fast glucose by multivariate analysis using the cardiovascular risk factors (R (2) = .396, P < .001). The plasma RANTES level is significantly associated with MS after adjusting for age (P = .040). Once plasma interleukin 6, an activator of platelets, and plasma platelet-derived microparticles, a marker for activated platelets, are put into the equation, plasma RANTES level is significantly correlated with the activated platelet-associated markers (R (2) = .396, P < .001). These suggest the possible role of elevated RANTES in the forerunner of atherosclerosis in healthy younger men.
© The Author(s) 2012.

Entities:  

Keywords:  RANTES; activated platelets; atherosclerosis; interleukin 6; metabolic syndrome; platelet-derived microparticle

Mesh:

Substances:

Year:  2014        PMID: 25301871     DOI: 10.1177/1076029612467845

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  8 in total

Review 1.  Clinical significance of procoagulant microparticles.

Authors:  Shosaku Nomura; Michiomi Shimizu
Journal:  J Intensive Care       Date:  2015-01-07

2.  Atorvastatin Decreased Circulating RANTES Levels in Impaired Glucose Tolerance Patients with Hypercholesterolemia: An Interventional Study.

Authors:  Xiaomeng Feng; Xia Gao; Yumei Jia; Heng Zhang; Yuan Xu
Journal:  Diabetes Ther       Date:  2017-01-24       Impact factor: 2.945

3.  Factors Associated with RANTES Concentration in Cardiovascular Disease Patients.

Authors:  Olga M Koper-Lenkiewicz; Joanna Kamińska; Anna Lisowska; Anna Milewska; Tomasz Hirnle; Violetta Dymicka-Piekarska
Journal:  Biomed Res Int       Date:  2019-07-18       Impact factor: 3.411

4.  Regulated upon activation, normal T cell expressed and secreted (RANTES) levels in the peripheral blood of patients with Alzheimer's disease.

Authors:  Gabriela Vacinova; Daniela Vejražkova; Robert Rusina; Iva Holmerová; Hana Vaňková; Eva Jarolímová; Josef Včelák; Běla Bendlová; Markéta Vaňková
Journal:  Neural Regen Res       Date:  2021-04       Impact factor: 5.135

5.  PPAR-α Agonist Fenofibrate Decreased RANTES Levels in Type 2 Diabetes Patients with Hypertriglyceridemia.

Authors:  Xiaomeng Feng; Xia Gao; Yumei Jia; Heng Zhang; Yuan Xu; Guang Wang
Journal:  Med Sci Monit       Date:  2016-03-05

6.  The utility of inflammation and platelet biomarkers in patients with acute coronary syndromes.

Authors:  Joanna Kamińska; Olga M Koper; Edyta Siedlecka-Czykier; Joanna Matowicka-Karna; Jerzy Bychowski; Halina Kemona
Journal:  Saudi J Biol Sci       Date:  2016-10-24       Impact factor: 4.219

7.  RANTES 59029A/G Polymorphisms Associated with Diabetic Compilations in Korean Patients with Type 2 Diabetes for over 15 Years.

Authors:  Dong-Hwa Lee; Eu-Jeong Ku; Tae-Keun Oh; Hyun-Jeong Jeon
Journal:  Genes (Basel)       Date:  2021-09-19       Impact factor: 4.096

8.  Dynamics of Soluble Factors and Double-Negative T Cells Associated with Response to Renal Denervation in Resistant Hypertension Patients.

Authors:  Joana Delgado-Silva; Paulo Rodrigues-Santos; Jani-Sofia Almeida; Manuel Santos-Rosa; Lino Gonçalves
Journal:  J Pers Med       Date:  2022-02-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.